Blackstone and TPG Pursue $4B-Plus Sale of Hologic Unit
Private equity giants Blackstone and TPG are jointly seeking more than $4 billion for a Hologic business unit, according to reports.
Blackstone and TPG are pursuing a sale valued at over $4 billion for a unit of medical technology company Hologic, according to a report cited by Seeking Alpha. The two private equity powerhouses are working together to offload the asset, signaling continued appetite among major buyout firms for large-scale healthcare divestitures even amid a choppy deal-making environment.
The move reflects a broader trend of private equity firms monetizing healthcare holdings acquired during a period of aggressive dealmaking. Hologic, known primarily for its women's health diagnostics and medical imaging products, has drawn attention from investors seeking exposure to defensive, high-margin healthcare assets.
Read more Crypto Markets Hold Steady Amid Rising Middle East Tensions →
A $4 billion-plus price tag would rank this among the more significant healthcare asset sales of the current cycle, underscoring how PE-backed healthcare platforms continue to command premium valuations despite rising interest rates and tighter credit conditions that have slowed leveraged buyout activity across other sectors.
Neither Blackstone nor TPG has publicly confirmed the reported process, and it remains unclear which specific Hologic division is being marketed or how far along the sale process may be. Outcomes will likely depend on strategic buyer interest from larger medtech companies as well as competing financial sponsors capable of financing a deal of this scale.
Continue reading at SeekingAlpha.
